Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

Published:2011-08-19 Issue:8 Volume:6 Page:e23109
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Santini Valeria,Girelli Domenico,Sanna Alessandro,Martinelli Nicola,Duca Lorena,Campostrini Natascia,Cortelezzi Agostino,Corbella Michela,Bosi Alberto,Reda Gianluigi,Olivieri Oliviero,Cappellini Maria Domenica

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Myelodysplastic syndromes.;A Tefferi;N Engl J Med,2009

2. Impact of iron overload in myelodysplastic syndromes.;P Fenaux;Blood Rev,2009

3. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.;L Malcovati;J Clin Oncol,2005

4. Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?;A Cortelezzi;Hematol J,2000

5. Hepcidin and disorders of iron metabolism.;T Ganz;Annu Rev Med,2011

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding iron homeostasis in MDS: the role of erythroferrone;Frontiers in Oncology;2024-05-21

2. Myelodysplastic Syndromes and Myelodysplastic Syndromes/Myeloproliferative Neoplasms: A Real-World Experience From a Developing Country;JCO Global Oncology;2024-02

3. The Role of Hepcidin in Myelodysplastic Syndromes (MDS): A Systematic Review of Observational Studies;Cancers;2024-01-11

4. Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR;Journal of Clinical Medicine;2023-10-17

5. Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study;Annals of Hematology;2023-09-08